| CEO Name | Albert Bourla |
| Nationality | Greece |
| Net Worth Estimation | $50 million |
Albert Bourla's estimated net worth of around $50 million stems from his executive compensation packages at Pfizer Inc., including salary, stock awards, bonuses, and accumulated Pfizer shares. His wealth is also influenced by performance-based incentives, long-term equity grants, and other corporate benefits associated with his CEO role.
Albert Bourla, CEO of Pfizer Inc., has an estimated net worth of $50,000,000, which is exactly halfway (50%) between the healthcare business category's minimum ($10,000,000) and maximum ($90,000,000) CEO net worth estimates. This places him at the median of the estimated CEO wealth range in the healthcare sector.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Albert Bourla Performance in Pfizer Inc.
Albert Bourla, CEO of Pfizer Inc., demonstrates strategic leadership by steering the company through groundbreaking vaccine development and global health challenges. His decisive decision-making accelerated the COVID-19 vaccine approval process, significantly boosting Pfizer's market value and global impact. Under Bourla's leadership, Pfizer achieved record performance, positioning it as a leader in pharmaceutical innovation and public health.
Latest News
Pfizer Inc. Advances Obesity Treatment and Secures Landmark U.S. Government Agreement Under CEO Albert Bourla
Pfizer, led by CEO Albert Bourla, is aggressively expanding in obesity treatments with a $4.9 billion acquisition of Metsera and has reached a landmark agreement with the U.S. government to lower drug costs while boosting U.S.-based manufacturing and research investments. Bourla emphasized the deal's benefit for American patients and Pfizer's stability in tariffs and pricing, citing a $70 billion investment plan in U.S. manufacturing and R&D over coming years.
Source: http://www.pfizer.com/newsroom/press-releases